Inezetamab is a bispecific anti-CD40 and anti-MSLN IgG1 monoclonal antibody.
References:
[1]. WHO Drug Information, Vol. 36, No. 3, 2022. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 1 mg | ¥5,850.00 | 现货 | 1 |
















Inezetamab is a bispecific anti-CD40 and anti-MSLN IgG1 monoclonal antibody.
References:
[1]. WHO Drug Information, Vol. 36, No. 3, 2022. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.